Immunogenicity in intravitreal anti-VEGF therapy: a call for balance and maturity in evaluating safety profiles
Int Ophthalmol
.
2024 Dec 5;44(1):445.
doi: 10.1007/s10792-024-03374-5.
Authors
Piergiorgio Neri
1
2
,
Yanny Perez Jimenez
3
,
Francesco Pichi
3
4
Affiliations
1
The Eye Department, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.
[email protected]
.
2
Cleveland Clinic Lerner College of Medicine of the Case Western Reserve University, Cleveland, OH, USA.
[email protected]
.
3
The Eye Department, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.
4
Cleveland Clinic Lerner College of Medicine of the Case Western Reserve University, Cleveland, OH, USA.
PMID:
39636473
DOI:
10.1007/s10792-024-03374-5
No abstract available
Publication types
Editorial